These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 28146130)

  • 1. Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD).
    Chen Q; Wang T; Li J; Wang S; Qiu F; Yu H; Zhang Y; Wang T
    Nutrients; 2017 Jan; 9(2):. PubMed ID: 28146130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kefir peptides prevent high-fructose corn syrup-induced non-alcoholic fatty liver disease in a murine model by modulation of inflammation and the JAK2 signaling pathway.
    Chen HL; Tsai TC; Tsai YC; Liao JW; Yen CC; Chen CM
    Nutr Diabetes; 2016 Dec; 6(12):e237. PubMed ID: 27941940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways.
    Li YC; Qiao JY; Wang BY; Bai M; Shen JD; Cheng YX
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
    Liu T; Luo X; Li ZH; Wu JC; Luo SZ; Xu MY
    World J Gastroenterol; 2019 Sep; 25(36):5451-5468. PubMed ID: 31576092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose surges damage hepatic adenosyl-monophosphate-dependent kinase and lead to increased lipogenesis and hepatic insulin resistance.
    Gugliucci A
    Med Hypotheses; 2016 Aug; 93():87-92. PubMed ID: 27372863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
    Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y
    J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring.
    Li M; Reynolds CM; Sloboda DM; Gray C; Vickers MH
    J Nutr Biochem; 2015 Mar; 26(3):267-76. PubMed ID: 25576095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
    Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
    Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid impairs fructose-driven de novo lipogenesis and ameliorates hepatic steatosis via AMPK-dependent suppression of SREBP-1/ACC/FASN cascade.
    Lu Y; Zhang C; Song Y; Chen L; Chen X; Zheng G; Yang Y; Cao P; Qiu Z
    Eur J Pharmacol; 2023 Feb; 940():175457. PubMed ID: 36529278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S; Hong J; Jeon R; Kim HS
    Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPARα and SCD-1.
    Zhang N; Wang Y; Zhang J; Liu B; Deng X; Xin S; Xu K
    FASEB J; 2020 Nov; 34(11):15338-15363. PubMed ID: 32996649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Korean Red Ginseng on metabolic syndrome.
    Yoon SJ; Kim SK; Lee NY; Choi YR; Kim HS; Gupta H; Youn GS; Sung H; Shin MJ; Suk KT
    J Ginseng Res; 2021 May; 45(3):380-389. PubMed ID: 34025131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringin attenuates fructose-induced NAFLD progression in rats through reducing endogenous triglyceride synthesis and activating the Nrf2/HO-1 pathway.
    Pengnet S; Sumarithum P; Phongnu N; Prommaouan S; Kantip N; Phoungpetchara I; Malakul W
    Front Pharmacol; 2022; 13():1049818. PubMed ID: 36588703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.